Loading...
Therapeutic Effect of Omalizumab in Severe Asthma: A Real-World Study in Korea
PURPOSE: Omalizumab, an anti-immunoglobulin E (IgE) monoclonal antibody, has proved to be effective for the treatment of severe asthma. However, there is no direct evidence of effectiveness of omalizumab in Korean patients with severe asthma. We sought to evaluate the real-world effectiveness of oma...
Na minha lista:
| Udgivet i: | Allergy Asthma Immunol Res |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5809760/ https://ncbi.nlm.nih.gov/pubmed/29411552 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4168/aair.2018.10.2.121 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|